Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesSleep MedicineBlue Cross RI HNS Coverage & Prior Auth Update | O…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

    Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts

    Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, prior authorization, and coverage stance for various surgical procedures for adult and pediatric OSA and snoring for Blue Cross Blue Shield - Rhode Island commercial products and Medicare Advantage where noted.

    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicySurgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateApr 1, 2026
    Next Review DateApr 1, 2026
    Key ActionObtain prior authorization (required for Medicare Advantage; recommended for Commercial) and document medical criteria in the online authorization tool before performing hypoglossal nerve stimulation.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ≥18minimum age for adult HNS eligibility
    15–100AHI range for adult HNS
    ≤35BMI threshold (adults)
    RequiredPrior authorization
    13–18Down syndrome adolescent eligibility

    Coverage Criteria for Surgical Treatment of Snoring and OSA

    Adult HNS medical necessity

    Hypoglossal nerve stimulation (Inspire device) may be considered medically necessary when ALL of the following are met:

    Adult HNS criteria: Age ≥ 18 yearsAge ≥ 18 years

    Applies to Inspire FDA-approved device for Commercial Products and Medicare Advantage where specified.

    Adult HNS criteria: Apnea-hypopnea index (AHI) ≥ 15 and ≤ 100 with less than 25% central apneasAHI ≥15 and ≤100; <25% central apneas

    Documented by appropriate sleep testing.

    Adult HNS criteria: CPAP failure or inability to tolerate CPAP (residual AHI ≥ 15 or failure to use CPAP ≥ 4 hours/night for ≥ 5 nights/week) or intoleranceResidual AHI ≥15 or CPAP use <4 hours/night for ≥5 nights/week

    Prior trial of CPAP required unless contraindicated.

    Adult HNS criteria: Body mass index ≤ 35 kg/m2BMI ≤ 35 kg/m2

    Clinical trials often enrolled patients with BMI ≤32–35; applies to selection for FDA-approved Inspire device.

    Adult HNS criteria: Absence of complete concentric collapse at the soft palate levelDocumented absence of complete concentric palatal collapse

    Anatomic assessment (eg, drug-induced sleep endoscopy) to confirm non-concentric collapse.

    Adolescent HNS (Down syndrome) medical necessity

    Hypoglossal nerve stimulation may be considered medically necessary in adolescents with Down syndrome when ALL of the following are met:

    Adolescent (Down syndrome) HNS criteria: Age 13 to 18 yearsAge 13–18 years

    Specific to adolescents/young adults with Down syndrome per policy language.

    Adolescent (Down syndrome) HNS criteria: AHI > 10 and < 50 with less than 25% central apneas after prior adenotonsillectomyAHI >10 and <50; <25% central apneas

    Prior adenotonsillectomy required when clinically appropriate.

    Adolescent (Down syndrome) HNS criteria: Either tracheotomy OR ineffective treatment with CPAP due to noncompliance, discomfort, undesirable side effects, persistent symptoms despite compliance, or refusal to use CPAPN/A

    Minimally invasive procedures not covered / considered not medically necessary

    Minimally invasive surgical procedures considered not covered / not medically necessary for OSA or snoring (selection):

    Not medically necessary procedures: Radiofrequency volumetric tissue reduction of the tongue (with or without palatal radiofrequency); Laser-assisted uvulopalatoplasty (LAUP); Radiofrequency volumetric reduction of palatal tissues; Palatal stiffening procedures (including cautery-assisted palatal stiffening, injection of sclerosing agents, and palatal implants); Tongue base suspension; All other minimally invasive surgical procedures not described as covered.N/A

    These procedures are considered not covered or not medically necessary for treatment of snoring without documented OSA; evidence insufficient to determine improvement in net health outcome.

    HNS patient selection criteria

    Covered when ALL of the following are met

    Age: Adults: Age ≥ 22 years; Adolescents with Down syndrome: age 10 to 21 yearsAdults ≥22 years; Adolescents 10–21 with Down syndrome

    Based on clinical study populations and expert opinion.

    OSA severity: Diagnosed moderate to severe obstructive sleep apnea with less than 25% central apneasModerate to severe OSA; <25% central apneas

    Documented by appropriate sleep testing (eg, polysomnography).

    Prior therapy: CPAP failure or inability to tolerate CPAPDocumented CPAP intolerance or failure (residual AHI ≥15 or inadequate use)

    Prior trial of CPAP required unless contraindicated.

    All minimally invasive interventions for snoring in the absence of documented obstructive sleep apnea (OSA) are not supported by evidence and are excluded from coverage. This includes procedures such as laser-assisted uvulopalatoplasty (LAUP), radiofrequency volumetric tissue reduction of the palate, and other palatal stiffening procedures; these interventions are considered not covered for the treatment of snoring alone because snoring without documented OSA is not considered a medical condition under this policy.

    The policy identifies specific procedure and billing codes that are not covered / not medically necessary for the treatment of OSA or snoring: 41512 (tongue base suspension, permanent suture technique), 41530 (submucosal ablation of the tongue base, radiofrequency), S2080 (laser-assisted uvulopalatoplasty, LAUP), and C9727 (insertion of implants into the soft palate; minimum of three implants). Claims for procedures without a specific CPT code should be filed with an appropriate unlisted procedure code.

    Services determined to be not medically necessary or otherwise non-covered under this policy are excluded from coverage in accordance with the member’s subscriber or employer agreement. Providers should note that eligibility and benefits are governed by the member’s subscriber agreement or certificate and that those documents supersede this medical policy.

    Hypoglossal nerve stimulation (HNS) performed with FDA‑approved devices other than the Inspire system (for example, Genio) is explicitly considered not medically necessary for treatment of clinically significant OSA for Commercial Products and therefore is not covered under this policy.

    The following minimally invasive tongue and palatal procedures are considered not medically necessary / not covered for OSA or snoring: tongue base suspension (CPT 41512), submucosal radiofrequency ablation of the tongue base (CPT 41530), laser-assisted uvulopalatoplasty (LAUP, S2080), and soft palate implants (HCPCS C9727). The policy states these procedures lack sufficient evidence to demonstrate improvement in health outcomes for OSA or snoring.

    If a service is determined to be not medically necessary or otherwise non-covered, it may be denied and not payable. Providers are advised to verify member-specific coverage and benefits with the provider call center prior to performing services, and to obtain any required prior written member agreement before billing a member for non-covered services.

    Coding — Procedure and HCPCS/CPT Codes

    Covered/considered medically necessary HNS CPT codesCPTCovered
    64582Hypoglossal nerve stimulation, appliance or device (documented in policy)
    64583Hypoglossal nerve stimulation, additional or related code (documented in policy)
    64568Percutaneous implantation of neurostimulator electrode maybe used for implantable hypoglossal nerve stimulation (policy references use for HNS)
    New HCPCS/Codes for HNS devicesmixedCovered
    C8007New code effective 1/1/2026 (referenced for HNS device)
    C8008New code effective 1/1/2026 (referenced for HNS device)
    C8011New code effective 1/1/2026 (referenced for HNS device)
    C8012New code effective 1/1/2026 (referenced for HNS device)
    Medically necessary CPT codes (Commercial & Medicare when criteria met)CPTCovered
    64582Open implantation of hypoglossal nerve neurostimulator array, pulse generator, and distal respiratory sensor electrode or electrode array
    64583Revision or replacement of hypoglossal nerve neurostimulator array and distal respiratory sensor electrode or electrode array, including connection to existing pulse generator
    New HCPCS/Codes Effective 1/1/2026 (Medicare/Commercial when criteria met)HCPCSCovered
    C8007Open implantation of hypoglossal nerve neurostimulator array and pulse generator, not requiring insertion of a separate distal respiratory sensor electrode or electrode array
    C8008Revision or replacement of hypoglossal nerve neurostimulator array including connection to existing pulse generator
    C8011Open implantation of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver, including external power source and all system components
    C8012Revision or replacement of hypoglossal nerve(s) neurostimulator electrode array(s) and receiver
    Additional covered CPT code for neurostimulator implantationCPTCovered
    64568Open implantation of cranial nerve (eg, vagus nerve) neurostimulator electrode array and pulse generator
    Codes not covered / not medically necessarymixedNot Covered
    41512Tongue base suspension, permanent suture technique
    41530Submucosal ablation of the tongue base, radiofrequency, 1 or more sites, per session
    S2080Laser-assisted uvulopalatoplasty (LAUP)
    C9727Insertion of implants into the soft palate; minimum of three implants
    AHI threshold — Adults & Adolescents (Down syndrome)
    Adult AHI thresholdAHI ≥15 and ≤100 with <25% central apneas
    Adolescent (Down syndrome) AHI thresholdAHI >10 and <50 with <25% central apneas (after prior adenotonsillectomy)
    Central apnea limit (applies to both groups)Less than 25% central apneas
    BMI threshold — Adults & Adolescents
    Adult BMI thresholdBody mass index ≤35 kg/m2
    Adolescent (Down syndrome) BMI threshold

    Provider Actions, Authorization, and Documentation

    Prior Authorization

    Prior authorization required for Medicare Advantage; recommended for Commercial

    Prior authorization is required for hypoglossal nerve stimulation (HNS) for Medicare Advantage Plans and is recommended for Commercial Products.

    Prior Authorization

    Prior authorization required for HNS procedure codes

    Prior authorization via the online authorization tool or Medicare Medical Necessity policy is required for implantable hypoglossal nerve stimulation CPT/HCPCS codes (e.g., 64582, 64583, 64568, C8007, C8008, C8011, C8012) to be considered medically necessary.

    Note

    Check member benefits and eligibility before authorization

    Verify member-specific benefits and eligibility with the provider call center and the online authorization tool before submitting authorization requests.

    Background

    Obstructive sleep apnea (OSA) is a disorder of recurrent upper airway collapse during sleep that can cause snoring, apneas, sleep fragmentation, daytime somnolence, and increased cardiopulmonary risk. Minimally invasive surgical approaches (including palatal and tongue base procedures) have been evaluated, but the evidence is insufficient for many of these techniques to demonstrate improved health outcomes. This policy therefore supports device‑based therapy meeting defined selection criteria (for example, hypoglossal nerve stimulation with the Inspire FDA‑approved system when criteria are met) and excludes or labels as not medically necessary several minimally invasive procedures for OSA and snoring as described above.

    Definitions and Terms

    Obstructive sleep apnea (OSA) — definition
    DefinitionObstructive sleep apnea (OSA) is characterized by repetitive episodes of upper airway obstruction during sleep causing apneas, snoring, sleep fragmentation, and excessive daytime sleepiness.
    Clinical consequencesOSA can lead to hypoxia, hypercapnia, systemic hypertension, cardiac arrhythmias, cor pulmonale, neurocognitive impairment in children, and increased accident risk.
    Typical signLoud snoring with abrupt cessations followed by gasping and arousals; cycle may repeat frequently throughout the night.
    Hypoglossal nerve stimulation (HNS) — definition
    DefinitionHypoglossal nerve stimulation (HNS) is an implantable device therapy that stimulates the hypoglossal nerve to produce tongue protrusion and stiffening of the anterior pharyngeal wall to reduce apneic events.
    Device example
    Policy Summary
    PayerBlue Cross Blue Shield - Rhode Island
    PolicySurgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateApr 1, 2026
    Next Review DateApr 1, 2026
    Key ActionObtain prior authorization (required for Medicare Advantage; recommended for Commercial) and document medical criteria in the online authorization tool before performing hypoglossal nerve stimulation.
    SourceLink
    On This Page
    Coverage Criteria for Surgical Treatment of Snoring and OSACoding — Procedure and HCPCS/CPT CodesProvider Actions, Authorization, and DocumentationBackgroundDefinitions and Terms

    Document reason for CPAP ineffectiveness or presence of tracheotomy.

    Adolescent (Down syndrome) HNS criteria: Body mass index ≤ 95th percentile for ageBMI ≤95th percentile for age

    Use pediatric growth charts to document percentile.

    Adolescent (Down syndrome) HNS criteria: Absence of complete concentric collapse at the soft palate levelDocumented absence of complete concentric palatal collapse

    Anatomic assessment recommended.

    BMI: Body mass index ≤ 32 kg/m2 in adults (some trials used ≤35 kg/m2)≤32 kg/m2 (trials sometimes enrolled ≤35 kg/m2)

    Evidence is limited in obese patients; use trial-specific thresholds as applicable.

    Anatomy: Favorable pattern of palatal collapse (non-concentric) documentedFavorable pattern documented

    Anatomic endotype associated with better outcomes; assessment may include drug-induced sleep endoscopy.

    Body mass index ≤95th percentile for age
    Evidence noteEfficacy of HNS in obese patients is limited; trials generally enrolled BMI ≤35 kg/m2
    CPAP use threshold for failure
    CPAP failure — residual AHIResidual AHI ≥15 while on CPAP
    CPAP failure — usageFailure to use CPAP ≥4 hours per night for ≥5 nights per week
    CPAP intoleranceInability to tolerate CPAP or documented intolerance despite trial
    BMI — evidence and selection thresholds
    Adult BMI selectionBody mass index ≤32 kg/m2 (some trials used ≤35 kg/m2)
    Trial enrollment noteRecent clinical trials generally enrolled patients with BMI ≤35 kg/m2
    Evidence limitationEvidence of HNS effectiveness is limited in obese patients
    Age — Adults & Adolescents with Down syndrome
    Adult age thresholdAdults: ≥22 years (policy cites ≥18 for device-specific criteria; selection criteria reference ≥22)
    Adolescent (Down syndrome) age rangeAdolescents/young adults with Down syndrome: 13–18 years (device-specific criteria); selection criteria consider age 10–21
    Note on age sourcesAge thresholds derive from device FDA labeling criteria and clinical study populations/selection criteria
    Central apnea proportion — requirement
    Central apnea proportionLess than 25% central apneas (required for HNS candidacy)
    Applies toAdults and adolescents with Down syndrome as specified in selection criteria
    Clinical rationaleSelection criteria and trials excluded patients with higher central apnea proportions
    • Benefits and eligibility are determined by the member's subscriber agreement or employer agreement and supersede this medical policy.
    • For member-specific benefits, call the provider call center.
    Step Therapy

    CPAP trial and documented failure/intolerance required

    Document a trial of CPAP demonstrating failure or intolerance before considering HNS: residual AHI ≥15 or inability to use CPAP ≥4 hours/night for ≥5 nights/week, or documented inability to tolerate CPAP.

    • CPAP failure is defined as residual AHI ≥15 or CPAP use <4 hours/night on ≥5 nights/week.
    Note
    Documentation Required

    Medicare Advantage: follow CMS NCD/LCD via online tool

    For Medicare Advantage, use CMS NCD/LCD medical necessity criteria in the online authorization tool for CPTs 64582 and 64583; new HCPCS codes C8007, C8008, C8011, and C8012 will be reviewed using the Medical Necessity criteria.

    • CPTs 64582 and 64583 follow CMS NCD/LCD criteria via the online tool.
    • New codes effective 1/1/2026 (C8007, C8008, C8011, C8012) are reviewed using Medical Necessity criteria.
    Documentation Required

    Document medical criteria in authorization tool or Medicare policy

    Medical criteria supporting HNS must be documented in the online authorization tool or the Medicare Medical Necessity policy for the applicable CPT/HCPCS codes to be considered medically necessary.

    • Documented criteria include age, AHI thresholds, CPAP failure/intolerance, BMI, and absence of complete concentric palatal collapse.
    Billing Rule

    Verify benefits and rely on subscriber agreements

    Providers must verify member-specific benefits and eligibility with the provider call center and rely on the member's subscriber or employer agreement, which supersedes this medical policy.

    • Confirm coverage prior to rendering services to avoid unexpected noncoverage.
    Prior Authorization

    Obtain prior authorization / confirm medical necessity via online tool

    Prior authorization is required for Medicare Advantage and recommended for Commercial; use the online authorization tool to confirm medical necessity criteria and required documentation before scheduling HNS.

    Prior Authorization

    Authorization required for procedures to be medically necessary

    Procedures will be considered medically necessary only when the medical criteria documented in the online authorization tool or the Medicare Medical Necessity policy have been met; failure to meet those authorization criteria may lead to denial.

    Denial Risk

    Denial risk and member financial liability for non-covered services

    If services are determined to be not medically necessary or non-covered, the claim may be denied and the provider may not charge the member unless the member has provided prior written agreement to self-pay.

    • Providers should confirm coverage and obtain written member agreement before billing the member for non-covered services.
    Inspire is the FDA‑approved device referenced in the policy for adult and select adolescent use.
    Evidence baseHNS is described in multiple trials, registries, and position statements cited in the policy references.
    Favorable pattern of palatal collapse — definition
    Favorable palatal collapse patternNon‑concentric palatal collapse (anatomic endotype) — a pattern considered favorable for adult HNS candidacy.
    Use in selectionRequired absence of complete concentric collapse at the soft palate level for HNS eligibility.
    SourceDefined from clinical trial populations and expert opinion referenced in policy selection criteria.
    CPAP failure or intolerance — definition and requirement
    CPAP failure — definitionCPAP failure is documented as residual AHI ≥15 on CPAP or failure to use CPAP ≥4 hours/night for ≥5 nights/week, or inability to tolerate CPAP.
    Clinical alternativesCPAP failure or intolerance is required before considering HNS in adults; adolescents with Down syndrome may be considered if CPAP is ineffective or not tolerated.
    DocumentationCPAP trial and failure/intolerance must be documented in authorization or medical records per the policy.
    Hypoglossal nerve stimulation — additional definition and references
    HNS — clinical definitionHypoglossal nerve stimulation is a surgical implant therapy that electrically stimulates the hypoglossal nerve to reduce upper airway collapse in OSA.
    Evidence and guidanceMultiple RCTs, systematic reviews, registries, and specialty society position statements (cited in the policy) inform HNS use and selection.
    Reference noteSee policy references including randomized trials (STAR and others), ADHERE registry, and professional society statements accessed 2025.